Carolien C.H.M. Maas

Publikationer
Populärvetenskap och samverkan

Artiklar

Journal article: CLINICAL TRANSPLANTATION. 2025;39(9):e70299
A Comprehensive Assessment of Plasma CXCL9 and CXCL10 in Improving Clinical Prediction Models for Kidney Allograft Rejection.
Souza AAD; Hesselink DA; Maas CCHM; Stubbs AP; Clahsen-van Groningen M; Baan CC; Klaveren DV; Boer K
Journal article: BJS-BRITISH JOURNAL OF SURGERY. 2025;112(4):znaf037
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy.
Stassen RC; Maas CCHM; Leong SP; Kashani-Sabet M; White RL; Pockaj BA; Zager JS; Schneebaum S; Vetto JT; Avisar E; Harrison Howard J; O'Donoghue C; Kosiorek H; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ; Olofsson Bagge R
Journal article: BMC HEALTH SERVICES RESEARCH. 2024;24(1):1469
Identifying persistent high-cost patients in the hospital for care management: development and validation of prediction models.
de Ruijter UW; Kaplan ZLR; Eijkenaar F; Maas CCHM; van der Heide A; Bax WA; Lingsma HF
Journal article: BLOOD CANCER JOURNAL. 2024;14(1):157
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Maas CCHM; van Klaveren D; Durmaz M; Visser O; Issa DE; Posthuma EFM; Zijlstra JM; Chamuleau MED; Lugtenburg PJ; Kersten MJ; Dinmohamed AG
Journal article: BMC MEDICAL RESEARCH METHODOLOGY. 2024;24(1):176
Pitfalls of single-study external validation illustrated with a model predicting functional outcome after aneurysmal subarachnoid hemorrhage.
de Winkel J; Maas CCHM; Roozenbeek B; van Klaveren D; Lingsma HF
Journal article: BMJ PUBLIC HEALTH. 2024;2(1):e000470
Disability weights for environmental noise-related health states: results of a disability weights measurement study in Europe.
Charalampous P; Maas CCHM; Haagsma JA
Journal article: LANCET ONCOLOGY. 2024;25(4):509-517
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Journal article: EBIOMEDICINE. 2024;102:105072
Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC
Journal article: STATISTICS IN MEDICINE. 2023;42(24):4514-4515
Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effects.
van Klaveren D; Maas CCHM; Kent DM
Journal article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):165
Performance metrics for models designed to predict treatment effect.
Maas CCHM; Kent DM; Hughes MC; Dekker R; Lingsma HF; van Klaveren D
Journal article: ECLINICALMEDICINE. 2023;60:101994
Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989-2019.
Maas CCHM; van Klaveren D; Visser O; Merkx MAW; Lingsma HF; Lemmens VEPP; Dinmohamed AG
Journal article: LEUKEMIA. 2022;36(5):1416-1420
Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era.
Dinnessen MAW; Maas CCHM; Tonino SH; Visser O; Posthuma EFM; Blijlevens NMA; Kersten MJ; Lugtenburg PJ; Dinmohamed AG
Journal article: BLOOD CANCER JOURNAL. 2022;12(4):72
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018.
van der Straten L; Maas CCHM; Levin M-D; Visser O; Posthuma EFM; Doorduijn JK; Langerak AW; Kater AP; Dinmohamed AG
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(5):1219-1224
The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018.
Maas CCHM; van Klaveren D; Ector GICG; Posthuma EFM; Visser O; Westerweel PE; Janssen JJWM; Blijlevens NMA; Dinmohamed AG

Alla övriga publikationer

Preprint: MEDRXIV. 2025;MEDRXIV
Potential clinical impact of predictive modeling of heterogeneous treatment effects: scoping review of the impact of the PATH Statement.
Selby JV; Maas CCHM; Fireman BH; Kent DM
Preprint: MEDRXIV. 2024;MEDRXIV
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference.
Maas CCHM; Kent DM; Dinmohamed AG; van Klaveren D
Preprint: MEDRXIV. 2022
Performance metrics for models designed to predict treatment effect
Maas CCHM; Kent DM; Hughes MC; Dekker R; Lingsma HF; van Klaveren D

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI